Issue 2/2012
Content (33 Articles)
Effect of obesity on toxicity in women treated with adjuvant chemotherapy for early-stage breast cancer: a systematic review
James Carroll, Melinda Protani, Euan Walpole, Jennifer H. Martin
Role of epidermal growth factor receptor in breast cancer
Hiroko Masuda, Dongwei Zhang, Chandra Bartholomeusz, Hiroyoshi Doihara, Gabriel N. Hortobagyi, Naoto T. Ueno
Mitochondria organelle transplantation: introduction of normal epithelial mitochondria into human cancer cells inhibits proliferation and increases drug sensitivity
R. L. Elliott, X. P. Jiang, J. F. Head
Phase II trial of temsirolimus in patients with metastatic breast cancer
Gini F. Fleming, Cynthia X. Ma, Dezheng Huo, Husain Sattar, Maria Tretiakova, L. Lin, Olwen M. Hahn, F. O. Olopade, R. Nanda, Philip C. Hoffman, M. J. Naughton, Timothy Pluard, Suzanne D. Conzen, Matthew J. Ellis
E-cadherin promotor methylation and mutation are inversely related to motility capacity of breast cancer cells
Remco van Horssen, Antoinette Hollestelle, Joost A. P. Rens, Alexander M. M. Eggermont, Mieke Schutte, Timo L. M. ten Hagen
mTORC1 is a target of nordihydroguaiaretic acid to prevent breast tumor growth in vitro and in vivo
Yue Zhang, Song Xu, Jun Lin, Guangyu Yao, Zelong Han, Bo Liang, Zhenhong Zou, Zhenguo Chen, Qiancheng Song, Yifan Dai, Tianming Gao, Anling Liu, Xiaochun Bai
Targeting the HOX/PBX dimer in breast cancer
Richard Morgan, Angie Boxall, Kevin J. Harrington, Guy R. Simpson, Cheryl Gillett, Agnieszka Michael, Hardev S. Pandha
Investigation of elemene-induced reversal of tamoxifen resistance in MCF-7 cells through oestrogen receptor α (ERα) re-expression
Bin Zhang, Xia Zhang, Bo Tang, Peishi Zheng, Yang Zhang
Cancer stem cell markers are associated with adverse biomarker profiles and molecular subtypes of breast cancer
Julia Y. S. Tsang, Yu-Hua Huang, Ming-Hua Luo, Yun-Bi Ni, Siu-Ki Chan, Philip C. W. Lui, Alex M. C. Yu, Puay Hoon Tan, Gary M. Tse
TOMM34 expression in early invasive breast cancer: a biomarker associated with poor outcome
Mohammed A. Aleskandarany, Ola H. Negm, Emad A. Rakha, Mohamed A. H. Ahmed, Christopher C. Nolan, Graham R. Ball, Carlos Caldas, Andrew R. Green, Patrick J. Tighe, Ian O. Ellis
Zerumbone causes Bax- and Bak-mediated apoptosis in human breast cancer cells and inhibits orthotopic xenograft growth in vivo
Anuradha Sehrawat, Julie A. Arlotti, Akira Murakami, Shivendra V. Singh
Bergapten induces ER depletion in breast cancer cells through SMAD4-mediated ubiquitination
M. L. Panno, F. Giordano, P. Rizza, M. Pellegrino, D. Zito, C. Giordano, L. Mauro, S. Catalano, S. Aquila, D. Sisci, F. De Amicis, A. Vivacqua, S. W. A. Fuqua, S. Andò
Surveillance of spontaneous breast cancer metastasis by TRAIL-expressing CD34+ cells in a xenograft model
Anna Rossini, Marta Giussani, Arianna Giacomini, Carla Guarnotta, Elda Tagliabue, Andrea Balsari
Efficacy of ‘radioguided occult lesion localisation’ (ROLL) versus ‘wire-guided localisation’ (WGL) in breast conserving surgery for non-palpable breast cancer: a randomised controlled multicentre trial
E. L. Postma, H. M. Verkooijen, S. van Esser, M. G. Hobbelink, G. P. van der Schelling, R. Koelemij, A. J. Witkamp, C. Contant, P. J. van Diest, S. M. Willems, I. H. M. Borel Rinkes, M. A. A. J. van den Bosch, W. P. Mali, R. van Hillegersberg
A randomized, controlled, double-blinded clinical trial of gabapentin 300 versus 900 mg versus placebo for anxiety symptoms in breast cancer survivors
Jill E. Lavigne, Charles Heckler, Jennifer L. Mathews, Oxana Palesh, Jeffrey J. Kirshner, Raymond Lord, Andrew Jacobs, Eric Amos, Gary R. Morrow, Karen Mustian
A randomized phase II trial of platinum salts in basal-like breast cancer patients in the neoadjuvant setting. Results from the GEICAM/2006-03, multicenter study
E. Alba, J. I. Chacon, A. Lluch, A. Anton, L. Estevez, B. Cirauqui, E. Carrasco, L. Calvo, M. A. Segui, N. Ribelles, R. Alvarez, A. Sanchez-Muñoz, R. Sanchez, J. A. Lopez Garcia-Asenjo, C. Rodriguez-Martin, M. J. Escudero, J. Albanell
Tamoxifen adherence and its relationship to mortality in 116 men with breast cancer
Shouping Xu, Yumei Yang, Weiyang Tao, Yanni Song, Yanbo Chen, Yanlv Ren, Jianxin Liu, Da Pang
Fulvestrant 500 mg versus anastrozole 1 mg for the first-line treatment of advanced breast cancer: follow-up analysis from the randomized ‘FIRST’ study
John F. R. Robertson, Justin P. O. Lindemann, Antonio Llombart-Cussac, Janusz Rolski, David Feltl, John Dewar, Laura Emerson, Andrew Dean, Matthew J. Ellis
Identification of factors associated with cancer related fatigue syndrome in disease-free breast cancer patients after completing primary treatment
Ollie Minton, Susanna Alexander, Patrick Charles Stone
Smoking and survival after breast cancer diagnosis: a prospective observational study and systematic review
Dejana Braithwaite, Monika Izano, Dan H. Moore, Marilyn L. Kwan, Martin C. Tammemagi, Robert A. Hiatt, Karla Kerlikowske, Candyce H. Kroenke, Carol Sweeney, Laurel Habel, Adrienne Castillo, Erin Weltzien, Bette Caan
Influence of health insurance, hospital factors and physician volume on receipt of immediate post-mastectomy reconstruction in women with invasive and non-invasive breast cancer
D. L. Hershman, C. A. Richards, K. Kalinsky, E. T. Wilde, Y. S. Lu, J. A. Ascherman, A. I. Neugut, J. D. Wright
Economic evaluation of radiotherapy for early breast cancer after breast-conserving surgery in a health resource-limited setting
Yongrui Bai, Ming Ye, Hongbin Cao, Xiumei Ma, Yuejuan Xu, Bin Wu
Breast cancer incidence by estrogen receptor status in Denmark from 1996 to 2007
J. Bigaard, C. Stahlberg, M.-B. Jensen, M. Ewertz, N. Kroman
A prognostic model of early breast cancer relapse after standard adjuvant therapy and comparison with metastatic disease on initial presentation
Li Chen, Edward Romond, Saurin Chokshi, Hayder Saeed, Jacob Hodskins, Mark Stevens, Grace Pasley, Heidi Weiss, Suleiman Massarweh
Aromatase inhibitors in obese breast cancer patients are not associated with increased plasma estradiol levels
Caroline Diorio, Julie Lemieux, Louise Provencher, Jean-Charles Hogue, Éric Vachon
Explaining age-related differences in depression following breast cancer diagnosis and treatment
Nancy E. Avis, Beverly Levine, Michelle J. Naughton, Douglas L. Case, Elizabeth Naftalis, Kimberly J. Van Zee
Associations between TCF7L2 polymorphisms and risk of breast cancer among Hispanic and non-Hispanic White women: the Breast Cancer Health Disparities Study
Avonne E. Connor, Richard N. Baumgartner, Kathy B. Baumgartner, Richard A. Kerber, Christina Pinkston, Esther M. John, Gabriela Torres-Mejia, Lisa Hines, Anna Giuliano, Roger K. Wolff, Martha L. Slattery
Through the lens of culture: quality of life among Latina breast cancer survivors
Kristi D. Graves, Roxanne E. Jensen, Janet Cañar, Monique Perret-Gentil, Kara-Grace Leventhal, Florencia Gonzalez, Larisa Caicedo, Lina Jandorf, Scott Kelly, Jeanne Mandelblatt
Comparing attendees with non-attendees in breast screening does not provide useful information about an effect on prognostic features or mortality
K. J. Jørgensen, M. Kalager, P. H. Zahl, V. M. Fønnebø
Expression of co-stimulators CD28/B7-1 in peripheral blood of patients with breast cancer
Jian Gong, Wen Pan, Chuanjia Yang, Feng Guo, Yunping Sun
Erratum to: Comparison of relative versus absolute arm size change as criteria for quantifying breast cancer-related lymphedema: the flaws in current studies and need for universal methodology
Marek Ancukiewicz, Cynthia L. Miller, Melissa N. Skolny, Jean O’Toole, Laura E. Warren, Lauren S. Jammallo, Michelle C. Specht, Alphonse G. Taghian
Erratum to: RETRACTED ARTICLE: Late phase activation of nuclear transcription factor kappaB by doxorubicin is mediated by interleukin-8 and induction of apoptosis via FasL
Charitha Gangadharan, Maikho Thoh, Sunil Kumar Manna